COMMUNIQUÉS West-GlobeNewswire

Standard Dental Labs Announces Acquisition Capital Strategy to Support Next Phase of Florida Expansion
21/07/2026
ORLANDO, Fla., July 21, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) ("SDL" or the "Company"), a consolidator of dental laboratories throughout Florida, today announced that its Board of Directors [...]
Propanc Biopharma Publishes Evaluation of Recombinant Trypsinogen & Chymotrypsinogen in Peer Reviewed Journal
21/07/2026
A Promising Strategy for Improving Production for Applications in Biotechnology Research MELBOURNE, Australia, July 21, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a [...]
Vivex Biologics Launches VIA Linx™, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advanced Wound Care Solutions
21/07/2026
New molecular medical device joins Vivex's growing suite of allograft and advanced wound care technologies MIAMI, July 21, 2026 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative [...]
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
21/07/2026
CLEVELAND, July 21, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced the activation [...]
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
21/07/2026
MELBOURNE, Australia and SAN FRANCISCO, July 21, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying [...]
Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
21/07/2026
WEST CHESTER, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a therapeutics company developing and commercializing medications for the treatment of dermatological [...]
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
21/07/2026
Transaction expands Jupiter into a dual clinical-stage CNS company by adding a differentiated FDA-designated Novel Chemical Entity alongside its Phase II Parkinson’s disease program JUPITER, FL, July 21, 2026 (GLOBE [...]
Merakris Therapeutics Awarded NIH Direct-to-Phase II SBIR Grant to Advance MTX-001 for Diabetic Foot Ulcers
21/07/2026
Award supports a two-year project expected to provide up to $2.2 million in non-dilutive funding while expanding Merakris' clinical-stage pipeline into a second major chronic wound indication RESEARCH TRIANGLE PARK, N.C [...]
Beacon Behavioral Partners Enters Michigan and Ohio Through Partnership with Pure Psychiatry
21/07/2026
Physician-led partnership establishes BBP's first presence in the Midwest, adding a 17-location behavioral health platform, creating a foundation for continued national growth PLANO, Texas, July 21, 2026 (GLOBE NEWSWIRE [...]
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
21/07/2026
Aggregate cash dividend of $17.3 million, or approximately $0.40242 per share NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of [...]
AssistRx and Medisafe Unite to Power Smarter, More Connected Patient Engagement
21/07/2026
Partnership delivers the real-time status updates and mobile-first engagement today's patients expect from therapy initiation through adherence ORLANDO, Fla., July 21, 2026 (GLOBE NEWSWIRE) -- AssistRx , the advanced [...]
Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026
21/07/2026
PLYMOUTH MEETING, Pa., July 21, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report second quarter 2026 financial results on Tuesday, August 4, 2026, before the [...]
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
21/07/2026
Initial customer wins bring VivoSim’s human-relevant liver and GI testing to the world’s second-largest pharmaceutical market SAN DIEGO, July 21, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company [...]
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
21/07/2026
Company receives positive pre-IND feedback from US FDA for CLD-401, indicating agreement on its current development strategy as it advances towards a first-in-human study; targeting dosing first patient in Q1 2027 [...]
Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types
21/07/2026
SCOTTSDALE, Ariz., July 21, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the [...]
Zhengye Biotechnology Holding Limited Comments on Unusual Trading Activity
21/07/2026
Jilin, China, July 21, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
21/07/2026
Technology License Partnership provides Genentech access to MaxCyte’s portfolio of platform technologies across research, development, and manufacturing workflows ROCKVILLE, Md., July 21, 2026 (GLOBE NEWSWIRE) -- [...]
Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time
21/07/2026
GERMANTOWN, Md., July 21, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on implantable Continuous Glucose Monitoring (CGM) Systems for people with diabetes, today [...]
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care
21/07/2026
Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announced ASC Solutions: an expanded enterprise strategy for ambulatory surgery centers (ASCs) that takes a customer-centric approach to [...]

Pages